| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |